These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 8574833)

  • 1. Serum antibody to lipopolysaccharide antigens of Shigella species among U.S. military personnel deployed to Saudi Arabia and Kuwait during Operations Desert Shield and Desert Storm.
    Hyams KC; Malone JD; Bourgeois AL; Hawkins R; Hale TL; Murphy JR
    Clin Diagn Lab Immunol; 1995 Nov; 2(6):700-3. PubMed ID: 8574833
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune response to Shigella sonnei in U.S. Marines.
    Mikhail MM; Mansour MM; Oyofo BA; Malone JD
    Infect Immun; 1996 Sep; 64(9):3942-5. PubMed ID: 8751956
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of antibodies to Shigella lipopolysaccharide in urine after natural Shigella infection or vaccination.
    Cohen D; Orr N; Robin G; Slepon R; Ashkenazi S; Ashkenazi I; Shemer J
    Clin Diagn Lab Immunol; 1996 Jul; 3(4):451-5. PubMed ID: 8807212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization and quantitative analysis of serum IgG class and subclass response to Shigella sonnei and Shigella flexneri 2a lipopolysaccharide following natural Shigella infection.
    Robin G; Cohen D; Orr N; Markus I; Slepon R; Ashkenazi S; Keisari Y
    J Infect Dis; 1997 May; 175(5):1128-33. PubMed ID: 9129076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative analysis of IgG class and subclass and IgA serum response to Shigella sonnei and Shigella flexneri 2a polysaccharides following vaccination with Shigella conjugate vaccines.
    Robin G; Keisari Y; Slepon R; Ashkenazi S; Cohen D
    Vaccine; 1999 Aug; 17(23-24):3109-15. PubMed ID: 10462247
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diarrheal disease during Operation Desert Shield.
    Hyams KC; Bourgeois AL; Merrell BR; Rozmajzl P; Escamilla J; Thornton SA; Wasserman GM; Burke A; Echeverria P; Green KY
    N Engl J Med; 1991 Nov; 325(20):1423-8. PubMed ID: 1656260
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Shigella-specific antibodies in the first year of life among Zambian infants: A longitudinal cohort study.
    Chisenga CC; Bosomprah S; Simuyandi M; Mwila-Kazimbaya K; Chilyabanyama ON; Laban NM; Bialik A; Asato V; Meron-Sudai S; Frankel G; Cohen D; Chilengi R
    PLoS One; 2021; 16(5):e0252222. PubMed ID: 34043697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum antibody responses against shigella lipopolysaccharides and invasion plasmid-coded antigens in shigella infected Swedish patients.
    Li A; Rong ZC; Ekwall E; Forsum U; Lindberg AA
    Scand J Infect Dis; 1993; 25(5):569-77. PubMed ID: 8284641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune Response Characterization after Controlled Infection with Lyophilized Shigella sonnei 53G.
    Clarkson KA; Frenck RW; Dickey M; Suvarnapunya AE; Chandrasekaran L; Weerts HP; Heaney CD; McNeal M; Detizio K; Parker S; Hoeper A; Bourgeois AL; Porter CK; Venkatesan MM; Kaminski RW
    mSphere; 2020 Sep; 5(5):. PubMed ID: 32968012
    [No Abstract]   [Full Text] [Related]  

  • 10. Shigella lipopolysaccharide antibodies in pediatric populations.
    Passwell JH; Freier S; Shor R; Farzam N; Block C; Lison M; Shiff E; Ashkenazi S
    Pediatr Infect Dis J; 1995 Oct; 14(10):859-65. PubMed ID: 8584312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Helicobacter pylori infection in Desert Storm troops.
    Taylor DN; Sanchez JL; Smoak BL; DeFraites R
    Clin Infect Dis; 1997 Nov; 25(5):979-82. PubMed ID: 9402341
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An inverse and independent association between Helicobacter pylori infection and the incidence of shigellosis and other diarrheal diseases.
    Cohen D; Shoham O; Orr N; Muhsen K
    Clin Infect Dis; 2012 Feb; 54(4):e35-42. PubMed ID: 22157171
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunoglobulin subclass distribution and dynamics of Shigella-specific antibody responses in serum and stool samples in shigellosis.
    Islam D; Wretlind B; Ryd M; Lindberg AA; Christensson B
    Infect Immun; 1995 May; 63(5):2054-61. PubMed ID: 7729920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibody in Lymphocyte Supernatant (ALS) responses after oral vaccination with live Shigella sonnei vaccine candidates WRSs2 and WRSs3 and correlation with serum antibodies, ASCs, fecal IgA and shedding.
    Venkatesan MM; Ballou C; Barnoy S; McNeal M; El-Khorazaty J; Frenck R; Baqar S
    PLoS One; 2021; 16(11):e0259361. PubMed ID: 34793505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and immunogenicity of improved Shigella O-specific polysaccharide-protein conjugate vaccines in adults in Israel.
    Passwell JH; Harlev E; Ashkenazi S; Chu C; Miron D; Ramon R; Farzan N; Shiloach J; Bryla DA; Majadly F; Roberson R; Robbins JB; Schneerson R
    Infect Immun; 2001 Mar; 69(3):1351-7. PubMed ID: 11179298
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum antibody titres to Shigella lipopolysaccharides and invasion plasmid antigens in healthy Costa Rican and Swedish women.
    Achí R; Mata L; Lindberg AA
    Scand J Infect Dis; 1994; 26(3):329-37. PubMed ID: 7939434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Presence of specific immunoglobulin A-secreting cells in peripheral blood after natural infection with Shigella sonnei.
    Orr N; Robin G; Lowell G; Cohen D
    J Clin Microbiol; 1992 Aug; 30(8):2165-8. PubMed ID: 1500527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Threshold protective levels of serum IgG to Shigella lipopolysaccharide: re-analysis of Shigella vaccine trials data.
    Cohen D; Ashkenazi S; Schneerson R; Farzam N; Bialik A; Meron-Sudai S; Asato V; Goren S; Baran TZ; Muhsen K; Gilbert PB; MacLennan CA
    Clin Microbiol Infect; 2023 Mar; 29(3):366-371. PubMed ID: 36243351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cross-reactivity of Shigella flexneri serotype 2a O antigen antibodies following immunization or infection.
    Van De Verg LL; Bendiuk NO; Kotloff K; Marsh MM; Ruckert JL; Puryear JL; Taylor DN; Hartman AB
    Vaccine; 1996 Aug; 14(11):1062-8. PubMed ID: 8879103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development, Interlaboratory Evaluations, and Application of a Simple, High-Throughput
    Nahm MH; Yu J; Weerts HP; Wenzel H; Tamilselvi CS; Chandrasekaran L; Pasetti MF; Mani S; Kaminski RW
    mSphere; 2018 Jun; 3(3):. PubMed ID: 29898979
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.